Could an innovative cancer treatment be used as a preventative vaccine? Arjan Griffioen and his team are determined to find out. These scientists have been developing proteins that specifically target cancer cells in the blood, leaving healthy tissue untouched. Every step of this journey—from vision to execution—has relied on the team’s dedication, as well as essential funding and investment. Spoiler alert: bringing the new treatment to market is not done overnight! Curious about the steps necessary? Watch the video to hear the full story by Arjan Griffioen and Else Huijbers.
A huge range of people need to be able to speak English in today’s globalised world. VU researcher Laura Rupp developed a Massive Open Online Course (MOOC), followed by more than 100,000 learners worldwide, teaching people how to understand the wide variety of accents in English and to speak more understandably themselves. She has also […]
In this Knowledge clip Alba Herranz de la Nava, Business Developer at IXA, explains, using the Triangle, how to make your idea more concrete: What is the problem that you are solving for your customer? Is there a NEED for the solution? Who are you solving it for? Who is prepared to pay for it? Why […]
Biobanks contain valuable information on the donor of the sample. Access to these collections can be crucial for companies developing novel diagnostics or therapeutics.